Adial Pharmaceuticals Inc
News
Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire GLEN ALLEN, Va., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ( Adial or the Company ), a clinical-stage biopharmaceutical company focused on developing therapies...\n more…
Contrasting Adial Pharmaceuticals (NASDAQ:ADIL) and Ultragenyx Pharmaceutical (NASDAQ:RARE)
Ticker Report Ultragenyx Pharmaceutical (NASDAQ:RARE - Get Free Report) and Adial Pharmaceuticals (NASDAQ:ADIL - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the...\n more…
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Increases By 8.3%
Ticker Report Adial Pharmaceuticals, Inc. (NASDAQ:ADIL - Get Free Report) saw a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling 318,900 shares...\n more…
Q3 2024 EPS Estimates for Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Decreased by Brookline Capital Management
Ticker Report Adial Pharmaceuticals, Inc. (NASDAQ:ADIL - Free Report) - Equities research analysts at Brookline Capital Management decreased their Q3 2024 earnings per share (EPS) estimates for shares of Adial...\n more…
Maxim Group Sticks to Its Hold Rating for Adial Pharmaceuticals (ADIL)
TipRanks Financial Blog In a report released yesterday, Jason McCarthy from Maxim Group maintained a Hold rating on Adial Pharmaceuticals (ADIL - Research Report). The com...\n more…
Adial Pharmaceuticals reports Q2 results
SeekingAlpha.com: All News Adial Pharmaceuticals press release (ADIL): Q2 net loss was $2.5 million for the three months ended June 30, 2024, compared to a net income of $1.1 million for the three months ended June 30\n more…